PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Shanxi Academy of Advanced Research and Innovation, Taiyuan 030032, China.\', \'Shanxi Provincial Key Laboratory for Major Infectious Disease Response, Taiyuan 030012, China.\', \'Chinese Academy of Sciences Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.\', \'Institutes of Biomedical Sciences, Shanxi University, Taiyuan 030006, China.\', \'Signet Therapeutics Inc, Shenzhen 518000, China.\', \'Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, National Institutes for Food and Drug Control, Beijing 102629, China huangweijin@nifdc.org.cn gaof@im.ac.cn jxqi@im.ac.cn guijun_shang@saari.org.cn.\', \'Shanxi Academy of Advanced Research and Innovation, Taiyuan 030032, China; huangweijin@nifdc.org.cn gaof@im.ac.cn jxqi@im.ac.cn guijun_shang@saari.org.cn.\', \'Chinese Academy of Sciences Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China; huangweijin@nifdc.org.cn gaof@im.ac.cn jxqi@im.ac.cn guijun_shang@saari.org.cn.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • e211757611910.1073/pnas.2117576119
?:hasPublicationType
?:journal
  • Proceedings of the National Academy of Sciences of the United States of America
is ?:pmid of
?:pmid
?:pmid
  • 35022217
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.092
?:rankingScore_hIndex
  • 675
is ?:relation_isRelatedTo_publication of
?:title
  • SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome/late endosome entry.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all